• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转谷氨酰胺酶 2 以应变依赖的方式促进小鼠伤口愈合。

Transglutaminase 2 Facilitates Murine Wound Healing in a Strain-Dependent Manner.

机构信息

Victor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia.

School of Clinical Medicine, UNSW Medicine and Health, University of New South Wales Sydney, Kensington, NSW 2052, Australia.

出版信息

Int J Mol Sci. 2023 Jul 14;24(14):11475. doi: 10.3390/ijms241411475.

DOI:10.3390/ijms241411475
PMID:37511238
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10380275/
Abstract

Transglutaminase 2 (TG2) plays a role in cellular processes that are relevant to wound healing, but to date no studies of wound healing in TG2 knockout mice have been reported. Here, using 129T2/SvEmsJ (129)- or C57BL/6 (B6)-backcrossed TG2 knockout mice, we show that TG2 facilitates murine wound healing in a strain-dependent manner. Early healing of in vivo cutaneous wounds and closure of in vitro scratch wounds in murine embryonic fibroblast (MEF) monolayers were delayed in 129, but not B6, TG2 knockouts, relative to their wild-type counterparts, with wound closure in 129 being faster than in B6 wild-types. A single dose of exogenous recombinant wild-type TG2 to 129 TG2 mice or MEFs immediately post-wounding accelerated wound closure. Neutrophil and monocyte recruitment to 129 cutaneous wounds was not affected by deletion up to 5 days post-wounding. mRNA and TG2 protein abundance were higher in 129 than in B6 wild-types and increased in abundance following cutaneous and scratch wounding. and factor XIIA () mRNA abundance increased post-wounding, but there was no compensation by TG family members in TG2 relative to TG2 mice in either strain before or after wounding. 129 TG2 MEF adhesion was greater and spreading was faster than that of B6 TG2 MEFs, and was dependent on syndecan binding in the presence, but not absence, of RGD inhibition of integrin binding. Adhesion and spreading of 129, but not B6, TG2 MEFs was impaired relative to their wild-type counterparts and was accelerated by exogenous addition or transfection of TG2 protein or cDNA, respectively, and was independent of the transamidase or GTP-binding activity of TG2. Rho-family GTPase activation, central to cytoskeletal organization, was altered in 129 TG2 MEFs, with delayed RhoA and earlier Rac1 activation than in TG2 MEFs. These findings indicate that the rate of wound healing is different between 129 and B6 mouse strains, correlating with TG2 abundance, and although not essential for wound healing, TG2 facilitates integrin- and syndecan-mediated RhoA- and Rac1-activation in fibroblasts to promote efficient wound contraction.

摘要

转谷氨酰胺酶 2(TG2)在与伤口愈合相关的细胞过程中发挥作用,但迄今为止,尚未有关于 TG2 基因敲除小鼠伤口愈合的研究报告。在这里,我们使用 129T2/SvEmsJ(129)或 C57BL/6(B6)回交 TG2 基因敲除小鼠,表明 TG2 以依赖于品系的方式促进小鼠伤口愈合。体内皮肤伤口的早期愈合和体外单层鼠胚胎成纤维细胞(MEF)划痕伤口的闭合在 129 中延迟,但在 B6 中不延迟,与野生型相比,129 的伤口闭合更快。在创伤后立即向 129 TG2 小鼠或 MEF 给予外源性重组野生型 TG2 可加速伤口闭合。在创伤后 5 天内,中性粒细胞和单核细胞向 129 皮肤伤口的募集不受缺失的影响。与 B6 野生型相比,129 的 mRNA 和 TG2 蛋白丰度更高,并且在皮肤和划痕创伤后增加。在两种品系中,创伤后 和因子 XIIA()mRNA 丰度增加,但在创伤前或创伤后,TG2 相对于 TG2 小鼠,TG 家族成员的丰度没有代偿。129 TG2 MEF 的黏附和铺展速度大于 B6 TG2 MEF,并且在存在 syndecan 结合的情况下依赖于整合素结合,但在不存在 RGD 抑制整合素结合的情况下则不然。129 的黏附和铺展相对于其野生型对照受损,但通过外源性添加或转染 TG2 蛋白或 cDNA 分别得到加速,并且独立于 TG2 的转胺酶或 GTP 结合活性。细胞骨架组织中的核心 Rho 家族 GTPase 激活在 129 TG2 MEF 中发生改变,与 TG2 MEF 相比,RhoA 激活延迟,Rac1 激活更早。这些发现表明,129 和 B6 小鼠品系之间的伤口愈合速度不同,与 TG2 丰度相关,尽管不是伤口愈合所必需的,但 TG2 促进整合素和 syndecan 介导的 RhoA 和 Rac1 激活,以促进有效的伤口收缩。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/5e62276cb959/ijms-24-11475-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/f18bca7c0098/ijms-24-11475-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/9b05cf843506/ijms-24-11475-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/b4bb4bb70ec3/ijms-24-11475-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/9d47d77760f1/ijms-24-11475-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/3d427fbdff0f/ijms-24-11475-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/72d15efb0692/ijms-24-11475-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/293845d99897/ijms-24-11475-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/d2f2e826c893/ijms-24-11475-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/9b150e34136a/ijms-24-11475-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/345d9314c1c1/ijms-24-11475-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/d2be3e186679/ijms-24-11475-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/5e62276cb959/ijms-24-11475-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/f18bca7c0098/ijms-24-11475-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/9b05cf843506/ijms-24-11475-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/b4bb4bb70ec3/ijms-24-11475-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/9d47d77760f1/ijms-24-11475-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/3d427fbdff0f/ijms-24-11475-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/72d15efb0692/ijms-24-11475-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/293845d99897/ijms-24-11475-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/d2f2e826c893/ijms-24-11475-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/9b150e34136a/ijms-24-11475-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/345d9314c1c1/ijms-24-11475-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/d2be3e186679/ijms-24-11475-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60fe/10380275/5e62276cb959/ijms-24-11475-g012.jpg

相似文献

1
Transglutaminase 2 Facilitates Murine Wound Healing in a Strain-Dependent Manner.转谷氨酰胺酶 2 以应变依赖的方式促进小鼠伤口愈合。
Int J Mol Sci. 2023 Jul 14;24(14):11475. doi: 10.3390/ijms241411475.
2
RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.通过组织转谷氨酰胺酶-纤维连接蛋白基质进行 RGD 非依赖性细胞黏附促进纤维连接蛋白纤维沉积,并且需要 syndecan-4/2α5β1 整联蛋白共信号传导。
J Biol Chem. 2010 Dec 17;285(51):40212-29. doi: 10.1074/jbc.M110.123703. Epub 2010 Oct 7.
3
Transglutaminase 2--a novel inhibitor of adipogenesis.转谷氨酰胺酶2——一种新型脂肪生成抑制剂。
Cell Death Dis. 2015 Aug 27;6(8):e1868. doi: 10.1038/cddis.2015.238.
4
Nitrosylation of tissue transglutaminase enhances fibroblast migration and regulates MMP activation.组织转谷氨酰胺酶的亚硝基化增强成纤维细胞迁移并调节基质金属蛋白酶的激活。
Matrix Biol. 2022 Jan;105:1-16. doi: 10.1016/j.matbio.2021.10.005. Epub 2021 Nov 9.
5
Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis.Syndecan-4基因敲除导致细胞外转谷氨酰胺酶-2减少,并可预防肾小管间质纤维化。
J Am Soc Nephrol. 2014 May;25(5):1013-27. doi: 10.1681/ASN.2013050563. Epub 2013 Dec 19.
6
Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN.转谷氨酰胺酶 2(TG2)丝氨酸-216 的磷酸化在 TG2 介导的核因子-κB 激活和 PTEN 的下调中起作用。
BMC Cancer. 2012 Jul 3;12:277. doi: 10.1186/1471-2407-12-277.
7
Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2).靶向组织转谷氨酰胺酶(TG2)的 PROTACs 的发现和表征。
J Med Chem. 2023 Jul 27;66(14):9445-9465. doi: 10.1021/acs.jmedchem.2c01859. Epub 2023 Jul 14.
8
Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family.转谷氨酰胺酶2的生物学功能及其由转谷氨酰胺酶家族其他成员代偿的可能性。
ScientificWorldJournal. 2014 Mar 23;2014:714561. doi: 10.1155/2014/714561. eCollection 2014.
9
Molecular mechanism of transglutaminase-2 in corneal epithelial migration and adhesion.转谷氨酰胺酶2在角膜上皮迁移和黏附中的分子机制
Biochim Biophys Acta. 2013 Jun;1833(6):1304-15. doi: 10.1016/j.bbamcr.2013.02.030. Epub 2013 Mar 4.
10
The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial-mesenchymal transition.转谷氨酰胺酶 2 与转化生长因子 β1 之间的功能关系在血管生成和内皮-间充质转化的调节中。
Cell Death Dis. 2017 Sep 7;8(9):e3032. doi: 10.1038/cddis.2017.399.

引用本文的文献

1
In Vitro Modulation of Macrophage Inflammatory and Pro-Repair Properties Essential for Wound Healing by Calcium and Calcium-Alginate Dressings.钙及海藻酸钙敷料对巨噬细胞炎症及促进伤口愈合修复特性的体外调节作用
Cells. 2025 Jun 16;14(12):909. doi: 10.3390/cells14120909.
2
Characterization and Physiological Differences of Two Primary Cultures of Human Normal and Hypertrophic Scar Dermal Fibroblasts: A Pilot Study.人正常及增生性瘢痕真皮成纤维细胞两种原代培养物的特性及生理差异:一项初步研究。
Biomedicines. 2024 Oct 10;12(10):2295. doi: 10.3390/biomedicines12102295.
3
Mesenchymal Transglutaminase 2 Activates Epithelial ADAM17: Link to G-Protein-Coupled Receptor 56 (ADGRG1) Signalling.

本文引用的文献

1
Mild Hyperthermia-Assisted ROS Scavenging Hydrogels Achieve Diabetic Wound Healing.温和升温辅助 ROS 清除水凝胶实现糖尿病伤口愈合。
ACS Macro Lett. 2022 Jul 19;11(7):861-867. doi: 10.1021/acsmacrolett.2c00290. Epub 2022 Jun 27.
2
Nitrosylation of tissue transglutaminase enhances fibroblast migration and regulates MMP activation.组织转谷氨酰胺酶的亚硝基化增强成纤维细胞迁移并调节基质金属蛋白酶的激活。
Matrix Biol. 2022 Jan;105:1-16. doi: 10.1016/j.matbio.2021.10.005. Epub 2021 Nov 9.
3
Wound healing: cellular mechanisms and pathological outcomes.
间质转谷氨酰胺酶 2 激活上皮 ADAM17:与 G 蛋白偶联受体 56(ADGRG1)信号的联系。
Int J Mol Sci. 2024 Feb 16;25(4):2329. doi: 10.3390/ijms25042329.
伤口愈合:细胞机制和病理结果。
Open Biol. 2020 Sep;10(9):200223. doi: 10.1098/rsob.200223. Epub 2020 Sep 30.
4
Toll-Like Receptor Function in Acute Wounds.急性伤口中的Toll样受体功能
Adv Wound Care (New Rochelle). 2017 Oct 1;6(10):344-355. doi: 10.1089/wound.2017.0734.
5
Glucose homeostasis in mice is transglutaminase 2 independent.小鼠的葡萄糖稳态与转谷氨酰胺酶 2 无关。
PLoS One. 2013 May 22;8(5):e63346. doi: 10.1371/journal.pone.0063346. Print 2013.
6
Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.组织转谷氨酰胺酶将 TGF-β、上皮到间充质转化和卵巢癌中的干细胞表型联系在一起。
Oncogene. 2012 May 17;31(20):2521-34. doi: 10.1038/onc.2011.429. Epub 2011 Oct 3.
7
RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.通过组织转谷氨酰胺酶-纤维连接蛋白基质进行 RGD 非依赖性细胞黏附促进纤维连接蛋白纤维沉积,并且需要 syndecan-4/2α5β1 整联蛋白共信号传导。
J Biol Chem. 2010 Dec 17;285(51):40212-29. doi: 10.1074/jbc.M110.123703. Epub 2010 Oct 7.
8
Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders.转谷氨酰胺酶与疾病:来自基因工程小鼠模型和遗传性疾病的启示
Physiol Rev. 2009 Jul;89(3):991-1023. doi: 10.1152/physrev.00044.2008.
9
Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling.纤连蛋白-组织转谷氨酰胺酶基质通过syndecan-4和β1整合素共信号传导挽救RGD受损的细胞黏附。
J Biol Chem. 2008 Jul 25;283(30):20937-47. doi: 10.1074/jbc.M801763200. Epub 2008 May 22.
10
Bupivacaine inhibits COX-2 expression, PGE2, and cytokine production in endotoxin-activated macrophages.布比卡因可抑制内毒素激活的巨噬细胞中COX-2的表达、前列腺素E2及细胞因子的产生。
Acta Anaesthesiol Scand. 2008 Apr;52(4):530-5. doi: 10.1111/j.1399-6576.2008.01590.x.